医学
荟萃分析
肠内给药
坏死性小肠结肠炎
随机对照试验
儿科
临床试验
相对风险
不利影响
新生儿学
败血症
肠外营养
重症监护医学
置信区间
怀孕
内科学
生物
遗传学
作者
Cathie Hilditch,Amy Keir,Carmel T Collins,Philippa Middleton,Judith Streak Gomersall
摘要
Aim To assess effects of early versus delayed introduction of human milk fortification in preterm infants. Methods We searched Cochrane Central Register of Controlled Trials, MEDLINE, Embase, PubMed and CINAHL for randomised controlled trials evaluating start time for human milk fortification in preterm infants (March 2020). Two authors assessed trial eligibility and risk of bias, extracted data and assessed evidence certainty. Results We identified 1307 publications and included three trials (378 infants). Meta‐analysis comparing fortification commencing at an enteral feed volume of ≤40 mL/kg/day versus ≥75 mL/kg/day, showed little to no difference in rates of necrotising enterocolitis (3 trials), sepsis (3 trials), feeding intolerance (2 trials) (low‐quality evidence) and infant growth (1 trial, very low‐quality evidence). Conclusions Whether early introduction of fortification, at an enteral feed volume of ≤40 mL versus delayed at ≥75 mL/kg/day improves growth or influences adverse feeding outcomes is very uncertain.
科研通智能强力驱动
Strongly Powered by AbleSci AI